Saori Suzuki Selected Research

Infections

1/2022	Inactivated whole influenza virus particle vaccines induce neutralizing antibodies with an increase in immunoglobulin gene subclones of B-lymphocytes in cynomolgus macaques.
1/2021	Efficacy of a Cap-Dependent Endonuclease Inhibitor and Neuraminidase Inhibitors against H7N9 Highly Pathogenic Avian Influenza Virus Causing Severe Viral Pneumonia in Cynomolgus Macaques.
5/2020	Animal Models Used in Hepatitis C Virus Research.
1/2020	Efficacy of Neuraminidase Inhibitors against H5N6 Highly Pathogenic Avian Influenza Virus in a Nonhuman Primate Model.
1/2019	Inactivated whole virus particle vaccine with potent immunogenicity and limited IL-6 induction is ideal for influenza.
1/2016	Persistent replication of a hepatitis C virus genotype 1b-based chimeric clone carrying E1, E2 and p6 regions from GB virus B in a New World monkey.
5/2012	Increased bovine Tim-3 and its ligand expressions during bovine leukemia virus infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Saori Suzuki Research Topics

Disease

7	Infections 01/2022 - 05/2012
4	Human Influenza (Influenza) 01/2022 - 01/2019
3	Influenza in Birds (Avian Flu) 01/2021 - 01/2020
3	Disease Progression 01/2021 - 05/2012
3	Deltaretrovirus Infections (BLV Infection) 02/2015 - 05/2012
2	Inflammation (Inflammations) 01/2021 - 08/2011
2	Anemia 07/2016 - 04/2010
2	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 07/2016 - 04/2010
1	Viral Pneumonia 01/2021
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2021
1	COVID-19 01/2021
1	Lung Injury 01/2020
1	Liver Diseases (Liver Disease) 01/2018
1	Diabetes Complications 10/2016
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2016
1	Disease Resistance 08/2012
1	Persistent Infection 05/2012
1	Foreign Bodies (Foreign Body) 08/2011
1	Autoimmune Diseases (Autoimmune Disease) 04/2010
1	Neoplasms (Cancer) 04/2009
1	Lymphatic Metastasis 11/2003
1	Laryngeal Neoplasms (Laryngeal Cancer) 11/2003

Drug/Important Bio-Agent (IBA)

5	VaccinesIBA 01/2022 - 01/2016
3	Ether (Diethyl Ether)IBA 01/2022 - 01/2019
3	Neuraminidase (Sialidase)IBA 01/2021 - 01/2020
2	Detergents (Detergent)IBA 01/2021 - 01/2019
2	Interferon-alpha (Interferon Alfa)IBA 01/2021 - 01/2020
2	Pharmaceutical PreparationsIBA 10/2016 - 11/2003
2	Superoxide Dismutase-1IBA 07/2016 - 04/2010
2	Messenger RNA (mRNA)IBA 02/2015 - 05/2012
1	Propiolactone FDA Link 01/2022
1	Formaldehyde (Formol)FDA Link 01/2022
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	Interleukin-13IBA 01/2021
1	EndonucleasesIBA 01/2021
1	Zanamivir (Relenza)FDA Link 01/2021
1	Oseltamivir (Tamiflu)FDA Link 01/2021
1	Pattern Recognition ReceptorsIBA 01/2021
1	baloxavirIBA 01/2021
1	Viral RNAIBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	Immune Checkpoint ProteinsIBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Aldehyde Reductase (Aldose Reductase)IBA 10/2016
1	EnzymesIBA 10/2016
1	Biological ProductsIBA 10/2016
1	Histocompatibility Antigens Class IIIBA 01/2013
1	CytokinesIBA 08/2012
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 05/2012
1	LigandsIBA 05/2012
1	MucinsIBA 05/2012
1	GelatinIBA 08/2011
1	AutoantibodiesIBA 04/2010
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2010
1	Proteins (Proteins, Gene)FDA Link 04/2009
1	titanium silicide (TS-1)IBA 11/2003

Therapy/Procedure

3	Therapeutics 01/2021 - 04/2009
1	Heterologous Transplantation (Xenotransplantation) 05/2020
1	Chemoradiotherapy 11/2003
1	Laryngectomy 11/2003